TH.TO - Theratechnologies Inc.

Toronto - Toronto Delayed Price. Currency in CAD

Theratechnologies Inc.

2015 Peel Street
5th Floor
Montreal, QC H3A 1T8

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees32

Key Executives

NameTitlePayExercisedYear Born
Mr. Luc TanguayPres, CEO & Non-Independent Director762.95kN/A1958
Mr. Philippe Dubuc MBASr. VP & CFO433.21kN/A1967
Mr. Jocelyn LafondVP of Legal Affairs & Corp. Sec.352.06kN/A1968
Mr. Denis Boucher B.A., L.L.B.VP of Communications & Corp. Affairs260.52kN/A1966
Mr. Christian MarsolaisSr. VP & Chief Medical Officer419.17kN/A1963
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Theratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.

Corporate Governance

Theratechnologies Inc.’s ISS Governance QualityScore as of October 4, 2019 is 6. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 9; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.